We are live on
!
Find out more
AWP
Accretive Wealth Partners Portfolio holdings
AUM
$412M
1-Year Est. Return
15.82%
This Fund
S&P 500
This Quarter
Est. Return
+6.54%
1 Year Est. Return
+15.82%
3 Year Est. Return
+57.32%
5 Year Est. Return
+67.02%
10 Year Est. Return
–
AUM
$226M
AUM Growth
+$17.9M
(+8.6%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
4.94%
Top 10 Holdings %
Top 10 Hldgs %
34.55%
Holding
141
New
11
Increased
68
Reduced
42
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.4M |
| 2 |
Humana
HUM
|
+$1.19M |
| 3 |
VeriSign
VRSN
|
+$1.13M |
| 4 |
Chevron
CVX
|
+$1.11M |
| 5 |
Microsoft
MSFT
|
+$744K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.36M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$872K |
| 3 |
Rollins
ROL
|
+$732K |
| 4 |
Marathon Petroleum
MPC
|
+$73K |
| 5 |
TransDigm Group
TDG
|
+$63K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Financials | 7.26% |
| 3 | Consumer Discretionary | 5.85% |
| 4 | Industrials | 5.48% |
| 5 | Communication Services | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Northrop Grumman
NOC
$77.9B
| $242K | 0.11% |
516
-12
| -2% | -$5.53K |
|
127
Elevance Health
ELV
$81.5B
| $234K | 0.1% |
444
| – | – |
|
128
Allstate
ALL
$68.3B
| $234K | 0.1% |
1,390
-45
| -3% | -$7.1K |
|
129
NVIDIA
NVDA
$4.84T
| $232K | 0.1% |
+2,610
| New | +$189K |
|
130
Markel Group
MKL
$23.5B
| $226K | 0.1% |
+143
| New | +$210K |
|
131
IQVIA
IQV
$38.4B
| $217K | 0.1% |
970
-140
| -13% | -$32.7K |
|
132
Global X FinTech ETF
FINX
$170M
| $213K | 0.09% |
8,400
| – | – |
|
133
American Express
AXP
$232B
| $208K | 0.09% |
+900
| New | +$187K |
|
134
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $202K | 0.09% |
+4,085
| New | +$197K |
|
|
EIGR
135
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $170K | 0.08% |
+63,150
| New | +$392K |
|
136
Douglas Elliman
DOUG
$155M
| $52.9K | 0.02% |
37,510
+2,500
| +7% | +$5.12K |
|
|
EVA
137
DELISTED
Enviva Inc.
EVA
| $5.58K | ﹤0.01% |
+10,951
| New | +$5.75K |
|
138
CALL
Transocean
RIG
$5.66B
| $1.04K | ﹤0.01% |
26,000
| – | – |
|
|
139
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
| – | – |
-9,542
| Closed | -$872K |
|
|
140
CVS Health
CVS
$133B
| – | – |
-17,245
| Closed | -$1.36M |
|
|
141
Rollins
ROL
$18.5B
| – | – |
-16,759
| Closed | -$732K |
|
Similar funds
CSUI
HIF
SCM
GCM
LCAM
TCCM
CW
LCM
Accretive Wealth Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Accretive Wealth Partners held 141 positions worth $226M, up 8.6% from $208M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Accretive Wealth Partners deployed $11.2M of net new capital in Q1 2024, opening 11 new positions and adding to 68 existing holdings. Its largest new stake was Humana: 3,149 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $73K trimmed.
- Accretive Wealth Partners's largest Q1 2024 buy was Humana: 3,149 shares worth $1.01M.
- Accretive Wealth Partners added most to Apple in Q1 2024, an estimated $3.4M increase.
- Accretive Wealth Partners's biggest Q1 2024 reduction was Marathon Petroleum, cutting an estimated $73K.
- Accretive Wealth Partners fully exited CVS Health in Q1 2024, selling an estimated $1.36M.
- Accretive Wealth Partners's ten largest holdings make up 35% of its $226M portfolio in Q1 2024.
- Accretive Wealth Partners opened 11 new positions and closed 3 in Q1 2024.
- Accretive Wealth Partners's portfolio value rose 8.6% quarter-over-quarter to $226M.
Based on Accretive Wealth Partners's 13F filing for Q1 2024, filed 6 May 2024.